Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs
JAMA
.
2019 Jun 25;321(24):2403-2404.
doi: 10.1001/jama.2019.5670.
Authors
Kathryn A Phillips
1
2
,
Julia R Trosman
1
3
,
Michael P Douglas
1
Affiliations
1
Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California, San Francisco.
2
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
3
Center for Business Models in Healthcare, Chicago, Illinois.
PMID:
31145414
PMCID:
PMC6684382
DOI:
10.1001/jama.2019.5670
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Clinical Laboratory Services*
Direct-To-Consumer Screening and Testing*
Genetic Testing / methods*
Humans
Laboratories
Physician's Role*
Grant support
R01 CA221870/CA/NCI NIH HHS/United States
R01 HG007063/HG/NHGRI NIH HHS/United States
U01 HG009599/HG/NHGRI NIH HHS/United States